TBPH – theravance biopharma, inc. - ordinary shares (US:NASDAQ)

News

B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 [Yahoo! Finance]
Theravance Stock Declines Around 17% in Three Months: Here's Why [Yahoo! Finance]
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com